BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Pieris Pharmaceuticals

Pieris Pharmaceuticals logo

Founded
2001
Geography
United States of America based
Funding
$67.100 M

Pieris Pharmaceuticals is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, inhaled Anticalin proteins to treat respiratory diseases, such as uncontrolled asthma, and a half-life-optimized Anticalin protein to treat anemia.

Technologies

Pharmaceutical and Drug Discovery  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet